Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Clinical trial NCT05080010 · RECRUITING
Trial details
- NCT number
- NCT05080010
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2030-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.